GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Other Operating Expense

Chi Sheng Pharma & Biotech Co (ROCO:4111) Other Operating Expense : NT$0 Mil (TTM As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Chi Sheng Pharma & Biotech Co Other Operating Expense?

Chi Sheng Pharma & Biotech Co's Other Operating Expense for the three months ended in Mar. 2025 was NT$0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0 Mil.

Chi Sheng Pharma & Biotech Co's quarterly Other Operating Expense stayed the same from Sep. 2024 (NT$0 Mil) to Dec. 2024 (NT$0 Mil) but then increased from Dec. 2024 (NT$0 Mil) to Mar. 2025 (NT$0 Mil).

Chi Sheng Pharma & Biotech Co's annual Other Operating Expense increased from Dec. 2022 (NT$-0 Mil) to Dec. 2023 (NT$0 Mil) but then stayed the same from Dec. 2023 (NT$0 Mil) to Dec. 2024 (NT$0 Mil).


Chi Sheng Pharma & Biotech Co Other Operating Expense Historical Data

The historical data trend for Chi Sheng Pharma & Biotech Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chi Sheng Pharma & Biotech Co Other Operating Expense Chart

Chi Sheng Pharma & Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Chi Sheng Pharma & Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Chi Sheng Pharma & Biotech Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chi Sheng Pharma & Biotech Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Chi Sheng Pharma & Biotech Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Chi Sheng Pharma & Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Shijian Road, Hsin Chu Industrial Park, Hsinchu County, Hukou, TWN, 30316
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.

Chi Sheng Pharma & Biotech Co Headlines

No Headlines